Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 1998;29:2196-2202

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Popa-Wagner, A.
Right arrow Articles by Futrell, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Popa-Wagner, A.
Right arrow Articles by Futrell, N.

(Stroke. 1998;29:2196-2202.)
© 1998 American Heart Association, Inc.


Original Contributions

ß-Amyloid Precursor Protein and ß-Amyloid Peptide Immunoreactivity in the Rat Brain After Middle Cerebral Artery Occlusion

Effect of Age

A. Popa-Wagner, PhD1; E. Schröder, MS1; L.C. Walker, PhD; C. Kessler, MD

From the Department of Neurology (A.P.-W., E.S., C.K.), University of Greifswald, Germany; and Parke-Davis (L.C.W.), Division of Warner-Lambert, Ann Arbor, Mich.

Correspondence to Aurel Popa-Wagner, PhD, Klinik für Neurologie, Ernst-Moritz-Arndt-Universität Greifswald, Ellernholzstr 1–2, 17487 Greifswald, Germany. E-mail wagner{at}neurologie.uni-greifswald.de

Background and Purpose—Previous studies have shown that the ß-amyloid precursor protein (ßAPP) is upregulated after cerebral ischemia and that the ß-amyloid (Aß) fragment may be toxic to brain cells. Although stroke in humans usually afflicts the elderly, most experimental studies on the nature of cerebral ischemia have used young animals. To test the hypothesis that the upregulation and/or persistence of amyloidogenic proteins is exacerbated in aged rats after cerebral ischemic stroke, we studied the expression of ßAPP and its proteolytic product Aß in the brains of young and old rats 7 days after temporary cerebral ischemia.

Methods—Focal cerebral ischemia was produced by reversible occlusion of the right middle cerebral artery in 3- and 20-month-old male Sprague-Dawley rats. After 1 week, brains were removed and immunostaining was performed for ßAPP, Aß, and ED1 for macrophages and glial fibrillary acidic protein (GFAP).

Results—Histological staining revealed that the degree of necrotic cavitation in the infarct core was relatively less in aged rats than in young rats, suggesting a slower pace of degenerative change and/or tissue removal in older animals. ßAPP immunoreactivity was robustly increased, primarily in macrophage-like, ED1-positive cells in the infarct core and in the penumbra of both young and aged animals. Aß immunoreactivity was evident in GFAP-positive astrocytic somata and processes, and also in clusters of small spherical structures in the penumbra. These Aß-immunoreactive minispheres were more numerous in aged rats than in young rats.

Conclusions—The presence of ßAPP and Aß immunoreactivity in the infarct core and penumbra indicates that cerebral ischemia promotes conditions that are favorable to the focal accumulation of ßAPP and its proteolytic fragments, especially in the aged brain.

Editorial Comment

Effect of Age

Nancy Futrell, MD, Guest Editor

Intermountain Stroke Research Foundation, Salt Lake City, Utah




This article has been cited by other articles:


Home page
J. Neurosci.Home page
S. F. Santos, N. Pierrot, N. Morel, P. Gailly, C. Sindic, and J.-N. Octave
Expression of Human Amyloid Precursor Protein in Rat Cortical Neurons Inhibits Calcium Oscillations
J. Neurosci., April 15, 2009; 29(15): 4708 - 4718.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
C. Justicia, P. Ramos-Cabrer, and M. Hoehn
MRI Detection of Secondary Damage After Stroke: Chronic Iron Accumulation in the Thalamus of the Rat Brain
Stroke, May 1, 2008; 39(5): 1541 - 1547.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. Lesne, C. Ali, C. Gabriel, N. Croci, E. T. MacKenzie, C. G. Glabe, M. Plotkine, C. Marchand-Verrecchia, D. Vivien, and A. Buisson
NMDA Receptor Activation Inhibits {alpha}-Secretase and Promotes Neuronal Amyloid-{beta} Production
J. Neurosci., October 12, 2005; 25(41): 9367 - 9377.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Mengesdorf, P. H. Jensen, G. Mies, C. Aufenberg, and W. Paschen
Down-regulation of parkin protein in transient focal cerebral ischemia: A link between stroke and degenerative disease?
PNAS, November 12, 2002; 99(23): 15042 - 15047.
[Abstract] [Full Text] [PDF]